Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seung Hwan Shin

Showing results (11-20 of 106) with videos related to

Pageof 11
Sort By:
Blood Research|July 17, 2019
Enhanced polo-like kinase 1 expression in myelodysplastic syndromesKyoung Il Min, Silvia Park, Seung-Hwan Shin, et al.
Transplantation and Cellular Therapy|October 6, 2022
Response and Dynamics of Renal Function in Transplantation-Eligible Multiple Myeloma Patients Treated with a Novel Agent: The CAREMM-2201 StudyYaeni Kim, Sung-Soo Park, Young-Woo Jeon, et al.
Journal of Gastroenterology and Hepatology|December 13, 2019
The number of wire placement in the pancreatic duct and metal biliary stent as risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitisSeung Hwan Shin, Hoonsub So, Sunghee Cho, et al.
International Journal of Hematology|April 23, 2013
Role of high-dose melphalan with autologous stem cell transplantation in multiple myeloma patients receiving botezomib-containing induction therapyBo-Hee Lee, Seung Hwan Shin, Chang-Ki Min, et al.
Blood Research|April 17, 2013
Hepatic veno-occlusive disease resulting in tacrolimus toxicity after allogeneic hematopoietic stem cell transplantationSeung-Hwan Shin, Seung-Ah Yahng, Jae-Ho Yoon, et al.
Blood Research|July 5, 2013
Acute colonic pseudo-obstruction following allogeneic stem cell transplantation successfully treated by neostigmineSeung-Ah Yahng, Jae-Ho Yoon, Seung-Hwan Shin, et al.
Journal of Cancer Research and Clinical Oncology|July 7, 2023
Comparisons of efficacy between frontline treatment with bortezomib-melphalan-prednisone and lenalidomide-dexamethasone for transplant-ineligible multiple myeloma: a multicenter real-world based registry report, CAREMM-2102 studyJung Yeon Lee, Sung-Soo Park, Young-Woo Jeon, et al.
Cancers|October 14, 2023
Prospective Comparative Study of Etoposide plus G-CSF versus G-CSF Alone, Followed by Risk-Adapted Plerixafor for Peripheral Blood Stem Cell Mobilization in Patients with Newly Diagnosed Multiple Myeloma: CAtholic REsearch Network for Multiple Myeloma Study (CAREMM-2001)Sung-Soo Park, Seung-Hwan Shin, Jung-Yeon Lee, et al.
Journal of Cancer Research and Clinical Oncology|September 12, 2023
Real-world treatment outcomes of carfilzomib plus dexamethasone in patients with relapsed and/or refractory multiple myeloma, focusing on the impact of trial-fitness: CAtholic REsearch network for Multiple Myeloma study (CAREMM-2203)Sung-Soo Park, Seo-Young Goo, Young-Woo Jeon, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|June 23, 2022
High failure rate after conservative treatment for recurrent shoulder dislocation without subjective apprehension on physical examinationWoo-Sung Do, Joo-Hyung Kim, Joon-Ryul Lim, et al.
Pageof 11

Showing results (11-20 of 106) with videos related to

Sort By:
Pageof 11
Blood Research|July 17, 2019
Enhanced polo-like kinase 1 expression in myelodysplastic syndromesKyoung Il Min, Silvia Park, Seung-Hwan Shin, et al.
Transplantation and Cellular Therapy|October 6, 2022
Response and Dynamics of Renal Function in Transplantation-Eligible Multiple Myeloma Patients Treated with a Novel Agent: The CAREMM-2201 StudyYaeni Kim, Sung-Soo Park, Young-Woo Jeon, et al.
Journal of Gastroenterology and Hepatology|December 13, 2019
The number of wire placement in the pancreatic duct and metal biliary stent as risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitisSeung Hwan Shin, Hoonsub So, Sunghee Cho, et al.
International Journal of Hematology|April 23, 2013
Role of high-dose melphalan with autologous stem cell transplantation in multiple myeloma patients receiving botezomib-containing induction therapyBo-Hee Lee, Seung Hwan Shin, Chang-Ki Min, et al.
Blood Research|April 17, 2013
Hepatic veno-occlusive disease resulting in tacrolimus toxicity after allogeneic hematopoietic stem cell transplantationSeung-Hwan Shin, Seung-Ah Yahng, Jae-Ho Yoon, et al.
Blood Research|July 5, 2013
Acute colonic pseudo-obstruction following allogeneic stem cell transplantation successfully treated by neostigmineSeung-Ah Yahng, Jae-Ho Yoon, Seung-Hwan Shin, et al.
Journal of Cancer Research and Clinical Oncology|July 7, 2023
Comparisons of efficacy between frontline treatment with bortezomib-melphalan-prednisone and lenalidomide-dexamethasone for transplant-ineligible multiple myeloma: a multicenter real-world based registry report, CAREMM-2102 studyJung Yeon Lee, Sung-Soo Park, Young-Woo Jeon, et al.
Cancers|October 14, 2023
Prospective Comparative Study of Etoposide plus G-CSF versus G-CSF Alone, Followed by Risk-Adapted Plerixafor for Peripheral Blood Stem Cell Mobilization in Patients with Newly Diagnosed Multiple Myeloma: CAtholic REsearch Network for Multiple Myeloma Study (CAREMM-2001)Sung-Soo Park, Seung-Hwan Shin, Jung-Yeon Lee, et al.
Journal of Cancer Research and Clinical Oncology|September 12, 2023
Real-world treatment outcomes of carfilzomib plus dexamethasone in patients with relapsed and/or refractory multiple myeloma, focusing on the impact of trial-fitness: CAtholic REsearch network for Multiple Myeloma study (CAREMM-2203)Sung-Soo Park, Seo-Young Goo, Young-Woo Jeon, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|June 23, 2022
High failure rate after conservative treatment for recurrent shoulder dislocation without subjective apprehension on physical examinationWoo-Sung Do, Joo-Hyung Kim, Joon-Ryul Lim, et al.
Pageof 11